September 17, 2014 5:39 PM ET

Pharmaceuticals

Company Overview of Ariel Pharmaceuticals, Inc.

Company Overview

Ariel Pharmaceuticals, Inc., a development-stage specialty pharmaceutical company, engages in the development and commercialization of products for indications in acute central nervous system diseases and trauma. The company develops drugs for the treatment of migraine, traumatic brain injury, hemorrhagic shock, and post-operative cognitive decline. Its products under development include AP-1531, which is an orally available, potent, and selective EP4 receptor antagonist for the treatment of acute migraine; AP-1100, an intravenous formulation of various therapeutic agents, including the sodium salt of b-hydroxybutyrate and a small molecule that readily crosses the blood brain barrier; and AP...

11001 West 120th Avenue

Suite 400

Broomfield, CO 80021

United States

Founded in 2011

Phone:

212-827-0020

Key Executives for Ariel Pharmaceuticals, Inc.

Chief Executive Officer and President
Managing Director
Vice President of Clinical Development
Vice President of R&D
Vice President of Manufacturing
Age: 62
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Biomedica Management Corporation United States
Meridian Animal Health, LLC United States
Theregen, Inc. United States
Dr. Reddy's Laboratories Tennessee, LLC United States
Quinnova Pharmaceuticals, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ariel Pharmaceuticals, Inc., please visit www.arielpharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.